Vote
Bury
1
Swiss pharmaceuticals and diagnostic group Roche plans to increase its China workforce by 25 percent this year, though it is likely to trim jobs in the United States and Europe.

Roche Group Chief Executive Officer Severin Schwan told China Daily that the company has established a complete value chain in China, and the new jobs will cover pharmaceutical research, clinical development, productio
Vote
Bury
1
SCIENTISTS from Shanghai Institute of Materia Medica under the Chinese Academy of Sciences have begun research into a new superbug which resists almost all antibiotics, institute officials said yesterday.

The bacteria, believed to have originated in India and which spread to other parts of the world after people traveled there for cheaper medical services, has so far infected 170 peo
Vote
Bury
1
Shareholder objection scuppered deal, says American company

American medical research equipment and services company Charles River Laboratories International Inc on Friday abandoned its $1.6 billion takeover of WuXi PharmaTech (Cayman) Inc, citing opposition from its shareholders to the deal.

New York-listed WuXi PharmaTech is a pharmaceutical and biotechnology research and developme
Vote
Bury
1
Drugmaker Merck Sharp & Dohme (MSD) started work on a new manufacturing site in Hangzhou on Monday as part of its expansion plans in China.

The 70,000 sq m manufacturing site in Hangzhou Economic and Technological Area has been set up with a total investment of 1.1 billion yuan and is one of the largest pharmaceutical packaging projects undertaken by Merck in recent times.

The unit is expec
FREELY you can publish and share with the other My China B2B Members:

 Your News
 Your Press Release
 Company presentations
 Fair / Exibitions introductions
 Opinions / Suggestions

ADD YOUR NEWS

Sort News
Subscribe Our Newsletter
Enter your Email


Preview
Our Partners

More Info My China B2B Club

Username:

Password:

Remember:
Follow us Follow us
Saved Stories